CoChat

Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility

Open access
Costello, M F, Misso, M L, Balen, A, Boyle, J, Devoto, L, Garad, R M, Hart, R, Johnson, L, Jordan, C, Legro, R S, Norman, R J, Mocanu, E, Qiao, J, Rodgers, R J, Rombauts, L, Tassone, E C, Thangaratinam, S, Vanky, E, Teede, H J, International PCOS Network · 2019 · Human Reproduction Open
Cited by 122

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

STUDY QUESTION: What is the recommended assessment and management of infertile women with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertize and consumer preference? SUMMARY ANSWER: International evidence-based guidelines, including 44 recommendations and practice points, addressed prioritized questions to promote consistent, evidence-based care and improve the experience and health outcomes of infertile women with PCOS. WHAT IS KNOWN ALREADY: Previous guidelines on PCOS lacked rigorous evidence-based processes, failed to engage consumer and multidisciplinary perspectives or were outdated. The assessment and management of infertile women with PCOS are inconsistent. The needs of women with PCOS are not being adequately met and evidence practice gaps persist. PARTICIPANTS/MATERIALS, SETTING, METHODS: Governance included a six continent international advisory and a project board, a multidisciplinary international guideline development group (GDG), consumer and translation committees. Extensive health professional and consumer engagement informed the guideline scope and priorities. The engaged international society-nominated panel included endocrinology, gynaecology, reproductive endocrinology, obstetrics, public health and other experts, alongside consumers, project management, evidence synthesis and translation experts. Thirty-seven societies and organizations covering 71 countries engaged in the process. Extensive online communication and two face-to-face meetings over 15 months addressed 19 prioritized clinical questions involving nine evidence-based reviews and 10 narrative reviews. Evidence-based recommendations (EBRs) were formulated prior to consensus voting within the guideline panel. STUDY DESIGN, SIZE, DURATION: International evidence-based guideline development engaged professional societies and consumer organizations with multidisciplinary experts and women with PCOS directly involved at all stages. A (AGREE) II-compliant processes were followed, with extensive evidence synthesis. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied across evidence quality, desirable and undesirable consequences, feasibility, acceptability, cost, implementation and ultimately recommendation strength. The guideline was peer-reviewed by special interest groups across our partner and collaborating societies and consumer organizations, was independently assessed against AGREE II criteria and underwent methodological review. This guideline was approved by all members of the GDG and has been approved by the NHMRC. MAIN RESULTS AND THE ROLE OF CHANCE: The quality of evidence (QOE) for the EBRs in the assessment and management of infertility in PCOS included very low (n = 1), low (n = 9) and moderate (n = 4) quality with no EBRs based on high-quality evidence. The guideline provides 14 EBRs, 10 clinical consensus recommendations (CCRs) and 20 clinical practice points on the assessment and management of infertility in PCOS. Key changes in this guideline include emphasizing evidence-based fertility therapy, including cheaper and safer fertility management. LIMITATIONS, REASONS FOR CAUTION: Overall evidence is generally of low to moderate quality, requiring significantly greater research in this neglected, yet common condition. Regional health systems vary and a process for adaptation of this guideline is provided. WIDER IMPLICATIONS OF THE FINDINGS: The international guideline for the assessment and management of infertility in PCOS provides clinicians with clear advice on best practice based on the best available evidence, expert multidisciplinary input and consumer preferences. Research recommendations have been generated and a comprehensive multifaceted dissemination and translation program supports the guideline with an integrated evaluation program. STUDY FUNDING/COMPETING INTEREST(S): The guideline was primarily funded by the Australian National Health and Medical Research Council of Australia (NHMRC) supported by a partnership with ESHRE and the American Society for Reproductive Medicine (ASRM). GDG members did not receive payment. Travel expenses were covered by the sponsoring organizations. Disclosures of conflicts of interest were declared at the outset and updated throughout the guideline process, aligned with NHMRC guideline processes. Dr Costello has declared shares in Virtus Health and past sponsorship from Merck Serono for conference presentations. Prof. Norman has declared a minor shareholder interest in the IVF unit Fertility SA, travel support from Merck and grants from Ferring. Prof. Norman also has scientific advisory board duties for Ferring. The remaining authors have no conflicts of interest to declare. This article was not externally peer-reviewed by Human Reproduction Open.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hropen/hoy021

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 114

  1. Abd Elgafor, 2013, Efficacy of combined metformin-letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome, Arch Gynecol Obstet, 1, 119, 10.1007/s00404-013-2714-2 · DOI
  2. Abdellah, 2011, Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome, Int J Gynaecol Obstet, 3, 218, 10.1016/j.ijgo.2010.11.026 · DOI
  3. Abu Hashim, 2012, Minimal stimulation or clomiphene citrate as first-line therapy in women with polycystic ovary syndrome: a randomized controlled trial, Gynecol Endocrinol, 2, 87, 10.3109/09513590.2011.589924 · DOI
  4. Abu Hashim, 2015, Combined metformin-clomiphene in clomiphene-resistant polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials, Acta Obstet Gynecol Scand, 9, 921, 10.1111/aogs.12673 · DOI
  5. Abu Hashim, 2011, Laparoscopic ovarian diathermy after clomiphene failure in polycystic ovary syndrome: is it worthwhile? A randomized controlled trial, Arch Gynecol Obstet, 5, 1303, 10.1007/s00404-011-1983-x · DOI
  6. Abu Hashim, 2010, Letrozole versus laparoscopic ovarian diathermy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial, Arch Gynecol Obstet, 5, 567, 10.1007/s00404-010-1566-2 · DOI
  7. Abu Hashim, 2010, Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial, Fertil Steril, 4, 1405, 10.1016/j.fertnstert.2009.07.985 · DOI
  8. Abu Hashim, 2011, Combined metformin and clomiphene citrate versus highly purified FSH for ovulation induction in clomiphene-resistant PCOS women: a randomised controlled trial, Gynecol Endocrinol, 3, 190, 10.3109/09513590.2010.488771 · DOI
  9. Al Subhi, 2013, Prevalence of tubal obstruction in the hysterosalpingogram of women with primary and secondary infertility, J Reprod Infertil, 4, 214
  10. Al-Inany, 2007, Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review, Reprod Biomed Online, 5, 640, 10.1016/S1472-6483(10)61059-0 · DOI · Paper page
  11. Amer, 2009, Randomized controlled trial comparing laparoscopic ovarian diathermy with clomiphene citrate as a first-line method of ovulation induction in women with polycystic ovary syndrome, Hum Reprod, 1, 219
  12. Atay, 2006, Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation, J Int Med Res, 1, 73, 10.1177/147323000603400109 · DOI · Paper page
  13. Badawy, 2009, Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial, Fertil Steril, 3, 849, 10.1016/j.fertnstert.2007.02.062 · DOI
  14. Bahceci, 2005, Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study, J Reprod Med, 2, 84
  15. Banerjee Ray, 2012, Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome, Arch Gynecol Obstet, 3, 873, 10.1007/s00404-011-2091-7 · DOI
  16. Baskind, 2016, Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome, Best Pract Res Clin Obstet Gynaecol, 37, 80, 10.1016/j.bpobgyn.2016.03.005 · DOI
  17. Bayar, 2006, Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial, Fertil Steril, 5, 1447, 10.1016/j.fertnstert.2006.04.026 · DOI
  18. Begum, 2013, Pretreatment and co-administration of oral anti-diabetic agent with clomiphene citrate or rFSH for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome, J Obstet Gynaecol Res, 5, 966, 10.1111/j.1447-0756.2012.02072.x · DOI
  19. Begum, 2009, Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome, Fertil Steril, 3, 853, 10.1016/j.fertnstert.2007.08.044 · DOI
  20. Bordewijk, 2017, Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome, Cochrane Database Syst Rev, 10.1002/14651858.CD009090.pub2 · DOI · Paper page
  21. Broeze, 2011, Are patient characteristics associated with the accuracy of hysterosalpingography in diagnosing tubal pathology? An individual patient data meta-analysis, Hum Reprod Update, 3, 293, 10.1093/humupd/dmq056 · DOI
  22. Brown, 2016, Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome, Cochrane Database Syst Rev, 12, Cd002249
  23. Chian, 2004, In-vitro maturation of immature oocytes for infertile women with PCOS, Reprod Biomed Online, 5, 547, 10.1016/S1472-6483(10)61101-7 · DOI
  24. Costello, 2006, A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome, Hum Reprod, 6, 1387, 10.1093/humrep/dei501 · DOI · Paper page
  25. Costello, 2012, The treatment of infertility in polycystic ovary syndrome: a brief update, Aust N Z J Obstet Gynaecol, 4, 400, 10.1111/j.1479-828X.2012.01448.x · DOI · Paper page
  26. Davies, 2012, Reproductive technologies and the risk of birth defects, N Engl J Med, 19, 1803, 10.1056/NEJMoa1008095 · DOI · Paper page
  27. De Vos, 2011, Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome, Fertil Steril, 4, 860, 10.1016/j.fertnstert.2011.07.1108 · doi:10.1016/j.fertnstert.2011.07.1108
  28. De Vos, 2016, The definition of IVM is clear-variations need defining, Hum Reprod, 11, 2411, 10.1093/humrep/dew208 · DOI
  29. Dehbashi, 2009, Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome, Iran J Med Sci, 1, 23
  30. Diamond, 2015, Letrozole, gonadotropin, or clomiphene for unexplained infertility, N Engl J Med, 13, 1230, 10.1056/NEJMoa1414827 · DOI · Paper page
  31. Elizur, 2008, Drugs in infertility and fetal safety, Fertil Steril, 89, 1595, 10.1016/j.fertnstert.2008.02.092 · DOI
  32. Farquhar, 2012, Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome, Cochrane Database Syst Rev, 2, CD001122
  33. Fedorcsak, 2003, The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial, Gynecol Endocrinol, 3, 207, 10.1080/gye.17.3.207.214 · doi:10.1080/gye.17.3.207.214
  34. Figen Turkcapar, 2013, Human menopausal gonadotropin versus recombinant FSH in polycystic ovary syndrome patients undergoing in vitro fertilization, Int J Fertil Steril, 4, 238
  35. Franik, 2014, Aromatase inhibitors for subfertile women with polycystic ovary syndrome, Cochrane Database Syst Rev, CD010287
  36. Ghanem, 2013, Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial, J Assist Reprod Genet, 11, 1477, 10.1007/s10815-013-0090-2 · DOI
  37. Gonzalez, 2015, Maternal and perinatal outcomes after bariatric surgery: a Spanish multicenter study, Obes Surg, 3, 436, 10.1007/s11695-014-1387-7 · DOI
  38. Goodman, 2015, American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - part 2, Endocr Pract, 12, 1415, 10.4158/EP15748.DSCPT2 · DOI · Paper page
  39. Hamed, 2010, Metformin versus laparoscopic ovarian drilling in clomiphene- and insulin-resistant women with polycystic ovary syndrome, Int J Gynecol Obstet, 108, 143, 10.1016/j.ijgo.2009.08.033 · DOI · Paper page
  40. Hamilton-Fairley, 1991, Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome, Hum Reprod, 8, 1095, 10.1093/oxfordjournals.humrep.a137491 · DOI · Paper page
  41. Haydardedeoglu, 2012, IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial, Arch Gynecol Obstet, 3, 763, 10.1007/s00404-012-2348-9 · doi:10.1007/s00404-012-2348-9
  42. Homburg, 2004, Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome, Best Pract Res Clin Obstet Gynaecol, 5, 773, 10.1016/j.bpobgyn.2004.05.006 · DOI
  43. Homburg, 2012, Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study, Hum Reprod, 2, 468, 10.1093/humrep/der401 · DOI · Paper page
  44. Huang, 2015, A systematic review and meta-analysis of metformin among patients with polycystic ovary syndrome undergoing assisted reproductive technology procedures, Int J Gynaecol Obstet, 2, 111, 10.1016/j.ijgo.2015.04.046 · DOI
  45. Hwang, 2004, Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study, Hum Reprod, 9, 1993, 10.1093/humrep/deh375 · DOI
  46. Ibrahim, 2017, Letrozole versus laparoscopic ovarian drilling in infertile women with PCOS resistant to clomiphene citrate, Middle East Fertil Soc J, 4, 251, 10.1016/j.mefs.2017.02.003 · DOI
  47. Imani, 2002, Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency, Fertil Steril, 1, 83, 10.1016/S0015-0282(01)02928-4 · DOI
  48. Imani, 1999, Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility, J Clin Endocrinol Metab, 5, 1617
  49. Jacobs, 1990, The endocrinology of conception, Baillieres Clin Endocrinol Metab, 2, 195, 10.1016/S0950-351X(05)80047-3 · doi:10.1016/s0950-351x(05)80047-3
  50. Johansson, 2015, Outcomes of pregnancy after bariatric surgery, N Engl J Med, 9, 814, 10.1056/NEJMoa1405789 · DOI · Paper page
  51. Johnson, 2010, PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene, Hum Reprod, 7, 1675, 10.1093/humrep/deq100 · DOI · Paper page
  52. Kar, 2012, Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial, J Hum Reprod Sci, 3, 262, 10.4103/0974-1208.106338 · DOI
  53. Karimzadeh, 2010, An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome, Fertil Steril, 1, 216, 10.1016/j.fertnstert.2009.02.078 · DOI · Paper page
  54. Kiddy, 1990, Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases, Clin Endocrinol (Oxf), 2, 213, 10.1111/j.1365-2265.1990.tb00857.x · DOI · Paper page
  55. Kjotrod, 2011, Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study, Hum Reprod, 8, 2045, 10.1093/humrep/der154 · DOI
  56. Kjotrod, 2004, Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study, Hum Reprod, 6, 1315, 10.1093/humrep/deh248 · DOI · Paper page
  57. Konig, 2013, Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study, Hum Reprod, 10, 2804, 10.1093/humrep/det266 · DOI
  58. Kurzawa, 2008, Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study, J Assist Reprod Genet, 8, 365, 10.1007/s10815-008-9249-7 · DOI
  59. Lager, 2017, Roux-En-Y gastric bypass vs. sleeve gastrectomy: balancing the risks of surgery with the benefits of weight loss, Obes Surg, 1, 154, 10.1007/s11695-016-2265-2 · DOI · Paper page
  60. Lainas, 2007, Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development, Hum Reprod, 6, 1540, 10.1093/humrep/dem033 · DOI
  61. Lainas, 2010, Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT), Hum Reprod, 3, 683, 10.1093/humrep/dep436 · DOI
  62. Legro, 2016, Ovulation induction in polycystic ovary syndrome: current options, Best Pract Res Clin Obstet Gynaecol, 37, 152, 10.1016/j.bpobgyn.2016.08.001 · DOI
  63. Legro, 2014, Letrozole versus clomiphene for infertility in the polycystic ovary syndrome, N Engl J Med, 2, 119, 10.1056/NEJMoa1313517 · DOI · Paper page
  64. Legro, 2014, Letrozole versus clomiphene for infertility in the polycystic ovary syndrome, N Engl J Med, 2, 119, 10.1056/NEJMoa1313517 · DOI · Paper page
  65. Lin, 2007, In vitro fertilization in the polycystic ovary syndrome patient: an update, Clin Obstet Gynecol, 1, 268, 10.1097/GRF.0b013e3180305fe4 · DOI
  66. Lin, 2014, Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs, PLoS One, 3, e91796, 10.1371/journal.pone.0091796 · DOI
  67. Lunde, 2001, Polycystic ovarian syndrome: a follow-up study on fertility and menstrual pattern in 149 patients 15–25 years after ovarian wedge resection, Hum Reprod, 7, 1479, 10.1093/humrep/16.7.1479 · DOI
  68. Lunenfeld, 1974, Classification of amenorrhoeic states and their treatment by ovulation induction, Clin Endocrinol (Oxf), 2, 223, 10.1111/j.1365-2265.1974.tb01799.x · DOI · Paper page
  69. Luttjeboer, 2009, The value of medical history taking as risk indicator for tuboperitoneal pathology: a systematic review, BJOG, 5, 612, 10.1111/j.1471-0528.2008.02070.x · DOI
  70. Maged, 2015, The adjuvant effect of metformin and N-acetylcysteine to clomiphene citrate in induction of ovulation in patients with Polycystic Ovary Syndrome, Gynecol Endocrinol, 8, 635, 10.3109/09513590.2015.1037269 · DOI
  71. Mancini, 2011, Gonadotrophin-releasing hormone-antagonists vs long agonist in in-vitro fertilization patients with polycystic ovary syndrome: a meta-analysis, Gynecol Endocrinol, 3, 150, 10.3109/09513590.2010.526667 · DOI
  72. Misso, 2012, Aromatase inhibitors for PCOS: a systematic review and meta-analysis, Hum Reprod Update, 3, 301, 10.1093/humupd/dms003 · DOI · Paper page
  73. Mokhtar, 2015, ART outcomes in GnRH antagonist protocol (Flexible) and long GnRH agonist protocol during early follicular phase in patients with polycystic ovary syndrome: a randomized clinical trial, J Reprod Infertil, 3, 148
  74. Mukherjee, 2010, Comparative evaluation of pregnancy outcome in gonadotrophin-clomiphene combination vs clomiphene alone in polycystic ovarian syndrome and unexplained infertility-A prospective clinical trial, J Hum Reprod Sci, 2, 80, 10.4103/0974-1208.69341 · DOI
  75. National Health and Medical Research Council, 2009, NHMRC levels of evidence and grades for recommendations for developers of guidelines
  76. National Institute for Health and Clinical Excellence, 2006, NICE clinical guideline 43: Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children
  77. Nazik, 2012, Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome, HealthMED, 3, 879
  78. Nugent, 2000, Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome, Cochrane Database Syst Rev, 4, CD000410
  79. Onalan, 2005, Metformin treatment in patients with polycystic ovary syndrome undergoing in vitro fertilization: a prospective randomized trial, Fertil Steril, 3, 798, 10.1016/j.fertnstert.2005.03.043 · DOI
  80. Palomba, 2011, Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial, Fertil Steril, 6, 1384, 10.1016/j.fertnstert.2011.09.020 · DOI
  81. Palomba, 2009, Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance, Curr Opin Obstet Gynecol, 21, 465, 10.1097/GCO.0b013e328332d188 · DOI · Paper page
  82. Palomba, 2009, Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis, Clin Endocrinol (Oxf), 2, 311, 10.1111/j.1365-2265.2008.03369.x · DOI · Paper page
  83. 2016, American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline, Fertil Steril, 7, 1634
  84. Pritts, 2010, Letrozole for ovulation induction and controlled ovarian hyperstimulation, Curr Opin Obstet Gynecol, 22, 289, 10.1097/GCO.0b013e32833beebf · DOI
  85. Pundir, 2012, Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS?, Reprod Biomed Online, 24, 6, 10.1016/j.rbmo.2011.09.017 · DOI
  86. Reavey, 2016, Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation, Cochrane Database Syst Rev, 11, CD008720
  87. Roesner, 2017, Time-lapse imaging reveals differences in growth dynamics of embryos after in vitro maturation compared with conventional stimulation, Fertil Steril, 3, 606, 10.1016/j.fertnstert.2016.12.026 · DOI
  88. Roesner, 2017, Two-year development of children conceived by IVM: a prospective controlled single-blinded study, Hum Reprod, 6, 1341, 10.1093/humrep/dex068 · doi:10.1093/humrep/dex068
  89. Roy, 2012, A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome, J Hum Reprod Sci, 1, 20, 10.4103/0974-1208.97789 · DOI · Paper page
  90. Sauerbrun-Cutler, 2015, In vitro maturation and its role in clinical assisted reproductive technology, Obstet Gynecol Surv, 1, 45, 10.1097/OGX.0000000000000150 · doi:10.1097/ogx.0000000000000150
  91. Schankath, 2012, Hysterosalpingography in the workup of female infertility: indications, technique and diagnostic findings, Insights Imaging, 5, 475, 10.1007/s13244-012-0183-y · DOI
  92. Schauer, 2017, Bariatric surgery or intensive medical therapy for diabetes after 5 years, N Engl J Med, 20, 1997
  93. Schwarze, 2016, Addition of neither recombinant nor urinary luteinizing hormone was associated with an improvement in the outcome of autologous in vitro fertilization/intracytoplasmatic sperm injection cycles under regular clinical settings: a multicenter observational analysis, Fertil Steril, 7, 1714, 10.1016/j.fertnstert.2016.09.003 · doi:10.1016/j.fertnstert.2016.09.003
  94. Scottish Intercollegiate Guidelines Network, 2010, Management of obesity: A national clinical guideline
  95. Selim, 2012, Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome, J Gynecol Surg, 6, 405, 10.1089/gyn.2012.0033 · DOI
  96. Sharma, 2014, Congenital malformations among babies born following letrozole or clomiphene for infertility treatment, PLoS One, 10, e108219, 10.1371/journal.pone.0108219 · DOI
  97. Sheikh-El-Arab Elsedeek, 2011, Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women, Middle East Fertil Soc J, 2, 125, 10.1016/j.mefs.2010.11.004 · DOI
  98. Stein, 1964, Duration of infertility following ovarian wedge resection, West J Surg, 72, 237
  99. Sturm, 2013, Morbid obesity rates continue to rise rapidly in the United States, Int J Obes (Lond), 6, 889, 10.1038/ijo.2012.159 · DOI · Paper page
  100. Tang, 2006, The use of metformin for women with PCOS undergoing IVF treatment, Hum Reprod, 6, 1416, 10.1093/humrep/del025 · DOI · Paper page
  101. Tarlatzis, 1995, The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques, Hum Reprod, 10, 2545, 10.1093/oxfordjournals.humrep.a135742 · DOI · Paper page
  102. Tatsumi, 2017, No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology, Hum Reprod, 32, 125
  103. Tehraninejad, 2010, Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients, Arch Gynecol Obstet, 3, 319, 10.1007/s00404-010-1429-x · doi:10.1007/s00404-010-1429-x
  104. Tso, 2014, Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome, Cochrane Database Syst Rev, 11, Cd006105
  105. Tulandi, 2006, Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate, Fertil Steril, 85, 1761, 10.1016/j.fertnstert.2006.03.014 · DOI · Paper page
  106. van Santbrink, 1995, Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients, Hum Reprod, 5, 1048, 10.1093/oxfordjournals.humrep.a136092 · DOI · Paper page
  107. van Wely, 2011, Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles, Cochrane Database Syst Rev, 2, CD005354
  108. Walls, 2015, In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes, Hum Reprod, 30, 88, 10.1093/humrep/deu248 · DOI · Paper page
  109. Walls, 2015, In vitro maturation is associated with increased early embryo arrest without impairing morphokinetic development of useable embryos progressing to blastocysts, Hum Reprod, 30, 1842, 10.1093/humrep/dev125 · doi:10.1093/humrep/dev125
  110. Wang, 2017, Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis, BMJ, 356, j138, 10.1136/bmj.j138 · DOI · Paper page
  111. White, 1996, Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women, J Clin Endocrinol Metab, 11, 3821
  112. Willis, 1998, Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation, J Clin Endocrinol Metab, 11, 3984
  113. Youssef, 2014, Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology, Cochrane Database Syst Rev, 10, Cd008046
  114. Zeinalzadeh, 2010, Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome, J Reprod Med, 1–2, 36

Cited by

See all 122

Metadata

Authors
Costello, M. F., Misso, M. L., Balen, A., Boyle, J., Devoto, L., Garad, R. M., Hart, R., Johnson, L., Jordan, C., Legro, R. S., Norman, R. J., Mocanu, E., Qiao, J., Rodgers, R. J., Rombauts, L., Tassone, E. C., Thangaratinam, S., Vanky, E., Teede, H. J., & International PCOS Network
Venue
Human Reproduction Open
Published
2019-01-01
Volume
2019
Issue
1
Pages
hoy021-hoy021
ISSN
2399-3529 (ISSN-L)
OpenAlex
W2926770468
Cited by
122
References
41
FWCI
9.88
Type
journal article
Language
en
Open access
gold
Funders
  • Australian National Health and Medical Research Council
  • NHMRC Centre for Research Excellence in Polycystic Ovary Syndrome
  • Monash University
  • University of Adelaide
  • ESHRE
  • American Society for Reproductive Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility. https://app.cochat.ai/papers/10.1093/hropen/hoy021
The paper
Costello, M. F., Misso, M. L., Balen, A., Boyle, J., Devoto, L., Garad, R. M., Hart, R., Johnson, L., Jordan, C., Legro, R. S., Norman, R. J., Mocanu, E., Qiao, J., Rodgers, R. J., Rombauts, L., Tassone, E. C., Thangaratinam, S., Vanky, E., Teede, H. J., & International PCOS Network. (2019). Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility. Human Reproduction Open. https://doi.org/10.1093/hropen/hoy021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.